PCM
SAGE

Palisade Capital Management’s Sage Therapeutics SAGE Stock Holding History

Palisade Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,163
Closed -$1.11M – 522
2016
Q3 		$1.11M Sell
24,163
-1,356
-5% -$55.2K 0.04% 402
2016
Q2 		$769K Buy
25,519
+1,522
+6% +$50.8K 0.03% 434
2016
Q1 		$769K Sell
23,997
-588
-2% -$20.7K 0.03% 441
2015
Q4 		$1.43M Sell
24,585
-1,230
-5% -$60.9K 0.05% 380
2015
Q3 		$1.09M Sell
25,815
-45,189
-64% -$2.78M 0.03% 403
2015
Q2 		$5.18M Sell
71,004
-1,793
-2% -$115K 0.13% 264
2015
Q1 		$3.66M Buy
+72,797
New +$3.13M 0.09% 302

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return